| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit monoclonal antibody anti-NEDD4 (1200-1300) is suitable for use in Western Blot research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
S5MR |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:1000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
NEDD4 |
| Gene ID: |
4734 |
| Uniprot ID: |
NEDD4_HUMAN |
| Immunogen Region: |
1200-1300 |
| Immunogen: |
A synthetic peptide corresponding to a sequence within amino acids 1200-1300 of human NEDD4 (P46934). |
| Immunogen Sequence: |
GDVDVNDWREHTKYKNGYSA NHQVIQWFWKAVLMMDSEKR IRLLQFVTGTSRVPMNGFAE LYGSNGPQSFTVEQWGTPEK LPRAHTCFNRLDLPPYESFE E |
| Post Translational Modifications | Undergoes 'Lys-29'-linked auto-ubiquitination at Lys-1279 and serves as a scaffold for recruiting USP13 to form an NEDD4-USP13 deubiquitination complex. |
| Function | E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Specifically ubiquitinates 'Lys-63' in target proteins. Involved in the pathway leading to the degradation of VEGFR-2/KDFR, independently of its ubiquitin-ligase activity. Monoubiquitinates IGF1R at multiple sites, thus leading to receptor internalization and degradation in lysosomes. Ubiquitinates FGFR1, leading to receptor internalization and degradation in lysosomes. Promotes ubiquitination of RAPGEF2. the direct link between NEDD4 and PTEN regulation through polyubiquitination described in PubMed:17218260 is questionable. Involved in ubiquitination of ERBB4 intracellular domain E4ICD. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. Ubiquitinates TNK2 and regulates EGF-induced degradation of EGFR and TNF2. Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1. Ubiquitinates DAZAP2, leading to its proteasomal degradation. Ubiquitinates POLR2A. Functions as a platform to recruit USP13 to form an NEDD4-USP13 deubiquitination complex that plays a critical role in cleaving the 'Lys-48'-linked ubiquitin chains of VPS34 and then stabilizing VPS34, thus promoting the formation of autophagosomes. (Microbial infection) Involved in the ubiquitination of Ebola virus protein VP40 which plays a role in viral budding. |
| Protein Name | E3 Ubiquitin-Protein Ligase Nedd4Cell Proliferation-Inducing Gene 53 ProteinHect-Type E3 Ubiquitin Transferase Nedd4Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 4Nedd-4 |
| Database Links | Reactome: R-HSA-1169408Reactome: R-HSA-1253288Reactome: R-HSA-8948747Reactome: R-HSA-8948751Reactome: R-HSA-983168 |
| Cellular Localisation | CytoplasmNucleusCell MembranePeripheral Membrane ProteinPredominantly Cytoplasmic But Also Located In The NucleusRecruited To The Plasma Membrane By Grb10Once Complexed With Grb10 And Igf1rFollows Igf1r InternalizationRemaining Associated With Early EndosomesUncouples From Igf1r-Containing Endosomes Before The Sorting Of The Receptor To The Lysosomal CompartmentMay Be Recruited To Exosomes By Ndfip1 |
| Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Nedd4 antibodyAnti-Cell Proliferation-Inducing Gene 53 Protein antibodyAnti-Hect-Type E3 Ubiquitin Transferase Nedd4 antibodyAnti-Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 4 antibodyAnti-Nedd-4 antibodyAnti-NEDD4 antibodyAnti-KIAA0093 antibodyAnti-NEDD4-1 antibodyAnti-RPF1 antibodyAnti-PIG53 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
